IGC Pharma Inc (IGC) is gearing up for another turning point as it hit the volume of 0.89 million

Steve Mayer

A new trading day began on Friday, with IGC Pharma Inc (AMEX: IGC) stock price down -4.61% from the previous day of trading, before settling in for the closing price of $0.39. IGC’s price has ranged from $0.25 to $0.50 over the past 52 weeks.

During the last 5-year period, the sales growth of Healthcare Sector giant was 12.85%. Meanwhile, its annual earnings per share averaged 11.11%. With a float of $67.31 million, this company’s outstanding shares have now reached $84.14 million.

IGC Pharma Inc (IGC) Insider Activity

As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of IGC Pharma Inc is 26.80%, while institutional ownership is 3.91%.

IGC Pharma Inc (IGC) Earnings and Forecasts

In its latest quarterly report, released on 9/30/2024, the company reported earnings of -0.02 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.02 per share during the current fiscal year.

IGC Pharma Inc (AMEX: IGC) Trading Performance Indicators

Here are IGC Pharma Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 0.46. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 25.44.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.08, a number that is poised to hit -0.02 in the next quarter and is forecasted to reach -0.09 in one year’s time.

Technical Analysis of IGC Pharma Inc (IGC)

Looking closely at IGC Pharma Inc (AMEX: IGC), its last 5-days average volume was 1.1 million, which is a drop from its year-to-date volume of 1.2 million. As of the previous 9 days, the stock’s Stochastic %D was 17.46%.

During the past 100 days, IGC Pharma Inc’s (IGC) raw stochastic average was set at 35.06%, which indicates a significant increase from 30.22% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.0275 in the past 14 days, which was higher than the 0.0253 volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $0.4082, while its 200-day Moving Average is $0.3416. However, in the short run, IGC Pharma Inc’s stock first resistance to watch stands at $0.3953. Second resistance stands at $0.4226. The third major resistance level sits at $0.4543. If the price goes on to break the first support level at $0.3363, it is likely to go to the next support level at $0.3046. Should the price break the second support level, the third support level stands at $0.2773.

IGC Pharma Inc (AMEX: IGC) Key Stats

With a market capitalization of 33.83 million, the company has a total of 91,959K Shares Outstanding. Currently, annual sales are 1,270 K while annual income is -7,120 K. The company’s previous quarter sales were 330 K while its latest quarter income was -1,600 K.

News Daemon
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.